Huma are partnering with Xyla Elective Care, a national provider of NHS England-funded elective services, to deliver tech-enabled virtual wards using Huma’s award-winning1 remote patient monitoring platform. The NHS has set a target for Trusts to ...
Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for OLUMIANT® (baricitinib) for the treatment of ...
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and First Serv, a Qatari investment holding company, today announced that they have entered into a non-binding Memorandum of Understanding (MOU) to develop and ...
Popular Posts
